iBio
IBIO
#10074
Rank
HK$0.21 B
Marketcap
HK$9.34
Share price
-6.25%
Change (1 day)
-53.65%
Change (1 year)

iBio (IBIO) - Total assets

Total assets on the balance sheet as of June 2025 : HK$0.18 Billion

According to iBio's latest financial reports the company's total assets are HK$0.18 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

iBio - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-06-30HK$0.22 B-30.51%
2023-06-30HK$0.32 B-58.61%
2022-06-30HK$0.78 B-31.64%
2021-06-30HK$1.14 B56.31%
2020-06-30HK$0.73 B205.53%
2019-06-30HK$0.23 B-29.34%
2018-06-30HK$0.33 B20.28%
2017-06-30HK$0.28 B-29.79%
2016-06-30HK$0.40 B313.46%
2015-06-30HK$96.84 M92.42%
2014-06-30HK$50.32 M-30.63%
2013-06-30HK$72.54 M-4.23%
2012-06-30HK$75.75 M32.69%
2011-06-30HK$57.08 M48.67%
2010-06-30HK$38.39 M0.5%
2009-06-30HK$38.2 M38.06%
2008-06-30HK$27.67 M-6.03%
2007-06-30HK$29.45 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Genocea Biosciences
GNCA
HK$0.30 B 67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.37 B 6,201.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$1.500 T 831,541.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$2.34 B 1,199.75%๐Ÿ‡บ๐Ÿ‡ธ USA